Hepatitis B virus mutation in children

被引:18
作者
Mei-Hwei Chang
机构
[1] National Taiwan University Hospital,Department of Pediatrics
关键词
Hepatitis B virus; Mutant; Immunoprophylaxis; Antiviral therapy;
D O I
10.1007/BF02790390
中图分类号
学科分类号
摘要
Due to the lack of proof reading activity of hepatitis B virus (HBV) polymerase, mutation/variation of the viral sequence is frequently found during long term follow-ups. In the majority of children with chronic HBV infection, wild type HBV is the dominant viral strain during the natural course of chronic HBV infection. During long-term follow-up, HBV precore mutants developed spontaneously in approximately 10 to 24% of children before HBeAg seroconversion, and in around 50% of children after HBeAg seroconversion mutants. Occasionally, children may be infected primarily by mutant strains of HBV. Approximately 36% of children with fulminant hepatitis and 30% of children with acute hepatitis B were infected by precore mutants of HBV transmitted by their mothers or blood donors. In addition, after universal HBV vaccination, HBV surface gene variants emerge or are selected under the immune pressure generated by the host or by administration of hepatitis B immune globulin and hepatitis B vaccination. In HBV DNA positive children from four sequential surveys in Taiwan, the prevalence of hepatitis B surface gene a determinant mutants increased from 7.8% before the vaccination program, to 19.6%, 28.1%, and 23.1% at 5, 10, and 15 years after the program. Nucleoside analogue may also induce mutant strains, which reduces the antiviral effects. The most common example is the YMDD mutation of the HBV polymerase gene after antiviral therapy with lamivudine. It developed in 19% of the treated children. In conclusion, children may be infected primarily by mutant strains of HBV either naturally during acute HBV infection. Those infected with wild type HBV initially may develop mutant strains gradually during the course of chronic infection under the host immune pressure. Vaccine escape mutants may develop after immunoprophylaxis. In addition, antiviral therapy with nucleoside anlogues may also induce drug resistant mutant strains. Understanding the viral mutation status will help to design accurate strategies of immunoprophylaxis and antiviral therapy against HBV infection.
引用
收藏
页码:803 / 807
页数:4
相关论文
共 80 条
[1]  
Nowak MA(1996)Viral dynamics in hepatitis B virus infection Proc Natl Acad Sci USA 93 4398-4402
[2]  
Bonhoeffer S(1987)Fulminant Hepatitis in children in Taiwan: The Important Role of Hepatitis B Virus J Pediatr 111 34-39
[3]  
Hill AM(1995)The significance of spontaneous HBeAg seroconversion in childhood: with special emphasis on the clearance of HBeAg before three years of age Hepatology 22 1387-1392
[4]  
Boehme R(1992)Cellular immune response to hepatitis B core antigen in maternal-infant transmission of hepatitis B virus Hepatology 15 770-776
[5]  
Thomas HC(2003)Hepatitis B virus genotypes Vaccine 23 2409-2423
[6]  
McDade H(2005)Therapeutic implications of hepatitis B virus genotypes Liver International 25 1097-1107
[7]  
Chang MH(2004)Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma Gastroenterology 127 1733-1738
[8]  
Lee CY(1998)Precore stop codon mutant in chronic hepatitis B virus infection in children: Its relation to hepatitis B e seroconversion and natural hepatitis B surface antigen J Heptology 28 915-922
[9]  
Chen DS(2004)Longitudinal study on mutation profiles of core promoter and precore regions of the hepatitis B virus genome in children Pediatr Research 56 396-399
[10]  
Hsu HC(2003)Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma GUT 52 122-125